• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Animal Biotechnology Market

    ID: MRFR/LS/7432-HCR
    128 Pages
    Rahul Gotadki
    October 2025

    Animal Biotechnology Market Research Report By Product Type (Cloning Services, Embryo Biotechnology, Gene Editing, In Vitro Fertilization (IVF), Marker Assisted Selection (MAS)), By Application (Livestock Production, Pet Care, Veterinary Diagnostics, Xenotransplantation, Wildlife Conservation), By Technology (CRISPR-Cas9, Gene Transfer, Genome Editing, Nanotechnology, RNA Interference), By Animal Type (Cattle, Poultry, Pets (Dogs and Cats), Horses, Other Animals (Pigs, Sheep, etc.)) and By Regional (North America, Europe, South America, Asia...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Animal Biotechnology Market Infographic
    Purchase Options

    Animal Biotechnology Market Summary

    The Global Animal Biotechnology Market is projected to grow from 19.37 USD Billion in 2024 to 58.44 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Animal Biotechnology Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 10.56% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 58.4 USD Billion, indicating substantial growth potential.
    • in 2024, the market is valued at 19.37 USD Billion, laying a strong foundation for future expansion.
    • Growing adoption of advanced genetic engineering techniques due to increasing demand for sustainable agricultural practices is a major market driver.

    Market Size & Forecast

    2024 Market Size 19.37 (USD Billion)
    2035 Market Size 58.44 (USD Billion)
    CAGR (2025-2035) 10.56%

    Major Players

    Zoetis, Merck Animal Health, Illumina, NEOGEN Corporation, QIAGEN, PerkinElmer, Pacific Biosciences of California, Eurofins Scientific, Boehringer Ingelheim Animal Health, BioRad Laboratories, Bayer Animal Health, Danaher Corporation, Agilent Technologies, Thermo Fisher Scientific, Elanco Animal Health, Oxford Nanopore Technologies

    Animal Biotechnology Market Trends

    The animal biotechnology market is witnessing significant growth due to technological advancements in molecular biology and genomics. The development of advanced techniques like gene editing and gene therapy holds immense potential for improving animal health and productivity.

    Furthermore, concerns over food safety and the growing demand for animal-based protein are driving the adoption of genetically modified animals, vaccines, and diagnostics.

    Additionally, the emergence of precision livestock farming practices is creating opportunities for data-driven decision-making and improved animal management.

    The market is anticipated to continue expanding as scientific breakthroughs and regulatory approvals open new possibilities in animal biotechnology.

    The Global Animal Biotechnology Market is poised for transformative growth, driven by advancements in genetic engineering and increasing demand for sustainable agricultural practices.

    U.S. Department of Agriculture

    Animal Biotechnology Market Drivers

    Market Growth Projections

    The Global Animal Biotechnology Market Industry is projected to experience substantial growth over the next decade. With an estimated value of 19.4 USD Billion in 2024, the market is anticipated to reach 58.4 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate (CAGR) of 10.56% from 2025 to 2035, reflecting the increasing integration of biotechnology in animal agriculture. Factors such as rising demand for animal-derived products, advancements in genetic engineering, and a focus on animal health and welfare are likely to contribute to this robust market expansion.

    Emerging Markets and Globalization

    The Global Animal Biotechnology Market Industry is witnessing growth in emerging markets, where increasing urbanization and rising incomes are driving demand for animal products. Countries in Asia-Pacific and Latin America are particularly notable for their expanding middle classes, which are shifting dietary preferences towards meat and dairy consumption. This trend is likely to create new opportunities for biotechnology applications in these regions, as producers seek to enhance productivity and meet consumer expectations. The globalization of food supply chains further amplifies this demand, suggesting a promising outlook for the market as it adapts to diverse regional needs.

    Focus on Animal Health and Welfare

    The Global Animal Biotechnology Market Industry is increasingly influenced by a heightened focus on animal health and welfare. Consumers are becoming more aware of the ethical implications of animal farming, leading to a demand for biotechnological solutions that promote better health outcomes for livestock. Innovations in vaccines, diagnostics, and therapeutics are essential for preventing diseases and ensuring the well-being of animals. This trend aligns with regulatory frameworks that emphasize animal welfare standards. As a result, investments in animal health biotechnology are likely to rise, further driving market growth and enhancing the overall sustainability of animal agriculture.

    Advancements in Genetic Engineering

    Technological innovations in genetic engineering significantly propel the Global Animal Biotechnology Market Industry. Techniques such as CRISPR and gene editing enable the development of genetically modified organisms that exhibit desirable traits, such as disease resistance and improved growth rates. These advancements not only enhance livestock productivity but also contribute to food security. As the global population continues to rise, the need for efficient food production systems becomes increasingly critical. The market is expected to grow at a CAGR of 10.56% from 2025 to 2035, indicating a robust future for genetic engineering applications in animal biotechnology.

    Rising Demand for Animal-Derived Products

    The Global Animal Biotechnology Market Industry experiences a surge in demand for animal-derived products, driven by increasing consumer preferences for meat, dairy, and other animal products. In 2024, the market is projected to reach 19.4 USD Billion, reflecting a growing population and changing dietary habits. This trend is likely to continue, with projections suggesting that by 2035, the market could expand to 58.4 USD Billion. The rising demand for high-quality and safe animal products necessitates advancements in biotechnology, which can enhance productivity and sustainability in animal agriculture.

    Regulatory Support and Funding Initiatives

    Governmental support and funding initiatives play a crucial role in shaping the Global Animal Biotechnology Market Industry. Various countries are implementing policies that encourage research and development in animal biotechnology, recognizing its potential to address food security and agricultural challenges. For instance, funding programs aimed at fostering innovation in biotechnology can lead to breakthroughs in animal health and production efficiency. This supportive regulatory environment is expected to facilitate market expansion, as stakeholders are more likely to invest in biotechnological solutions that align with national agricultural goals and sustainability objectives.

    Market Segment Insights

    Animal Biotechnology Market Product Type Insights

    The  Animal Biotechnology Market is segmented by product type into cloning services, embryo biotechnology, gene editing, in vitro fertilization, and marker assisted selection. Gene editing is expected to grow at the highest rate in the  animal biotechnology market over the forecast period, due to a high adoption rate in animal breeding and research.

    Cloning services increase the number of genetically identical cloned animals, usually for research or conservation. This provides all cloned animals with the same DNA.

    This segment will grow steadily throughout the forecast period, and the  demand for cloned animals in biomedical research and the development of new cloning techniques will be vital.

    The manipulation of a part of or the whole embryo to improve specific animal traits such as growth rate, resistance to diseases and fertility is referred to as embryo biotechnology. This segment will grow slowly during the forecast period due to ethics and regulatory issues.

    Gene editing, also known as genome editing, refers to the use of technologies to make precise changes to an animal’s DNA. The  gene editing segment will grow significantly during the forecast period, given potential applications in animal breeding, disease management, and research in the creation of new animal models.

    Animal Biotechnology Market Application Insights

    The  Animal Biotechnology Market segmentation by Application includes Livestock Production, Pet Care, Veterinary Diagnostics, Xenotransplantation, and Wildlife Conservation. The Livestock Production segment is expected to dominate the market with a significant market share due to the growing demand for animal-derived products such as meat, milk, and eggs.

    The Pet Care segment is also expected to grow steadily due to the increasing pet ownership and spending on pet healthcare. Veterinary Diagnostics holds a considerable market share owing to the rising prevalence of animal diseases and the need for accurate and rapid diagnostics.

    Xenotransplantation and Wildlife Conservation segments are relatively smaller but are expected to gain traction in the coming years due to advancements in biotechnology and the need for organ transplantation and wildlife conservation efforts.

    Animal Biotechnology Market Technology Insights

    CRISPR-Cas9, gene transfer, genome editing, nanotechnology, and RNA interference are prominent technologies driving the growth of the  Animal Biotechnology Market. CRISPR-Cas9 technology offers precise genome editing capabilities, enabling scientists to modify genes with high accuracy.

    Gene transfer involves introducing foreign genes into animal cells to alter their genetic makeup and enhance desirable traits. Genome editing techniques allow researchers to make targeted changes to DNA, facilitating the development of disease-resistant and improved livestock breeds.

    Nanotechnology finds application in animal biotechnology for drug delivery, disease diagnostics, and tissue engineering. RNA interference technology enables the regulation of gene expression, providing a powerful tool for studying gene function and developing therapeutics.

    The  Animal Biotechnology Market segmentation by technology helps stakeholders identify specific growth opportunities and develop targeted strategies to capitalize on the advancements in these technologies.

    Animal Biotechnology Market Animal Type Insights

    The  Animal Biotechnology Market is segmented by animal type into Cattle, Poultry, Pets (Dogs and Cats), Horses, and Other Animals (Pigs, Sheep, etc.). Among these segments, the Cattle segment held the largest market share in 2023, owing to the increasing demand for animal biotechnology products for cattle breeding and disease prevention.

    The Poultry segment is also expected to witness significant growth in the coming years, driven by the rising demand for poultry products and the need for efficient disease management practices.

    The Pets (Dogs and Cats) segment is expected to grow steadily, driven by the increasing adoption of pets and the growing awareness of pet health and well-being. The horse segment is also expected to experience growth, driven by the demand for biotechnology products for horse breeding and performance enhancement.

    The Other Animals (Pigs, Sheep, etc.) segment is expected to witness moderate growth, driven by the growing demand for animal biotechnology products for disease prevention and productivity improvement.

    Overall, the Animal Type segment of the  Animal Biotechnology Market is expected to witness significant growth in the coming years, driven by the increasing demand for animal biotechnology products across various animal types.

    Get more detailed insights about Animal Biotechnology Market Research Report - Global Forecast till 2034

    Regional Insights

    The Animal Biotechnology Market is segmented into North America, Europe, APAC, South America, and MEA. North America dominated the market in 2023 with a revenue of USD 5.24 billion, owing to the presence of major market players, advanced research infrastructure, and high adoption of animal biotechnology in the region.

    Europe is expected to witness significant growth during the forecast period, driven by government initiatives to promote animal health and welfare and rising demand for animal-derived products.

    APAC is projected to be the fastest-growing region, with a CAGR of 12.5% during the forecast period, due to increasing investments in animal biotechnology research and development and growing demand for animal-derived products in the region.

    South America and MEA are expected to experience moderate growth, owing to the increasing adoption of animal biotechnology in livestock production and rising awareness about animal health and welfare.

    Animal Biotechnology Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    Major players in the Animal Biotechnology Market are constantly striving to gain a competitive edge by investing in research and development, expanding their product portfolios, and forming strategic partnerships.

    Leading Animal Biotechnology Market players are actively involved in developing innovative technologies, such as gene editing and reproductive technologies, to meet the growing demand for improved animal health and productivity.

    The Animal Biotechnology Market development is driven by factors such as increasing demand for animal-derived products, rising concerns about animal welfare, and advancements in genetic engineering techniques.

    Animal Biotechnology Market Competitive Landscape is characterized by the presence of both established and emerging players, with each company focusing on specific areas of expertise to differentiate themselves in the market.

    A leading company in the  Animal Biotechnology Market is Zoetis, which offers a wide range of products and services for animal health and nutrition. Zoetis has a strong focus on research and development, with a dedicated team of scientists working on developing innovative solutions for animal care.

    The company's product portfolio includes vaccines, antibiotics, parasiticides, and other treatments for various animal species. Zoetis has a  presence, with operations in over 100 countries and a strong distribution network. The company's commitment to animal health and well-being has made it a trusted partner for veterinarians and animal owners worldwide.

    A competitor company in the  Animal Biotechnology Market is Merck Animal Health, which is also a major player in the industry. Merck Animal Health offers a comprehensive range of products, including vaccines, pharmaceuticals, and other solutions for animal health.

    The company has a strong focus on innovation, with a dedicated research and development team working on developing new and improved products. Merck Animal Health has a  presence, with operations in over 150 countries and a strong distribution network.

    The company's commitment to animal health and well-being has made it a trusted partner for veterinarians and animal owners worldwide. Merck Animal Health's competitive strategies include investing in research and development, expanding its product portfolio, and forming strategic partnerships to gain a competitive edge in the market.

    Key Companies in the Animal Biotechnology Market market include

    Industry Developments

    • Q3 2024: Elanco Animal Health invested over USD 130 million in August 2024 to expand its Kansas, U.S. factory by 25,000 square feet and subsequently increase the capability for producing veterinary biologics. Elanco Animal Health announced a $130 million investment to expand its Kansas manufacturing facility by 25,000 square feet, aiming to boost production capacity for veterinary biologics.

    Future Outlook

    Animal Biotechnology Market Future Outlook

    The Global Animal Biotechnology Market is projected to grow at a 10.56% CAGR from 2025 to 2035, driven by advancements in genetic engineering, increasing demand for sustainable livestock, and enhanced animal health solutions.

    New opportunities lie in:

    • Develop CRISPR-based solutions for livestock genetic enhancement.
    • Invest in biopharmaceuticals targeting animal diseases.
    • Create innovative feed additives to improve animal health and productivity.

    By 2035, the Animal Biotechnology Market is expected to reach new heights, reflecting robust growth and innovation.

    Market Segmentation

    Animal Biotechnology Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia-Pacific
    • Middle East and Africa

    Animal Biotechnology Market Technology Outlook

    • CRISPR-Cas9
    • Gene Transfer
    • Genome Editing
    • Nanotechnology
    • RNA Interference

    Animal Biotechnology Market Animal Type Outlook

    • Cattle
    • Poultry
    • Pets (Dogs and Cats)
    • Horses
    • Other Animals (Pigs, Sheep, etc.)

    Animal Biotechnology Market Application Outlook

    • Livestock Production
    • Pet Care
    • Veterinary Diagnostics
    • Xenotransplantation
    • Wildlife Conservation

    Report Scope

    Animal Biotechnology Market Report Scope
    Report Attribute/Metric Details
    Market Size 2024   19.37 (USD Billion)
    Market Size 2025   21.41 (USD Billion)
    Market Size 2035 58.44 (USD Billion)
    Compound Annual Growth Rate (CAGR) 10.56% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2020 - 2024
    Market Forecast Units USD Billion
    Key Companies Profiled Illumina, NEOGEN Corporation, QIAGEN, PerkinElmer, Pacific Biosciences of California, Eurofins Scientific, Boehringer Ingelheim Animal Health, BioRad Laboratories, Bayer Animal Health, Zoetis, Danaher Corporation, Agilent Technologies, Thermo Fisher Scientific, Elanco Animal Health, Oxford Nanopore Technologies, Merck
    Segments Covered Product Type, Application, Technology, Animal Type, Regional
    Key Market Opportunities 1 Gene editing for disease resistance 2 Enhanced nutrition and feed efficiency 3 Precision breeding for desirable traits 4 Diagnostics and personalized treatments 5 Animal welfare and sustainable practices
    Key Market Dynamics Rising demand for animal protein Technological advancements in genetic engineering Increasing prevalence of animal diseases Growing awareness of animal welfare Expansion of the pet industry
    Countries Covered North America, Europe, APAC, South America, MEA
       

    FAQs

    What is the market size of the Animal Biotechnology market?

    The Animal Biotechnology market was valued at USD 15.84 billion in 2023 and is expected to reach USD 39.1 billion by 2032, exhibiting a CAGR of 10.56% during the forecast period.

    Which region is expected to dominate the Animal Biotechnology market?

    North America is expected to dominate the Animal Biotechnology market throughout the forecast period due to the presence of major market players, advanced research infrastructure, and increasing adoption of animal biotechnology in livestock production.

    What are the key growth drivers of the Animal Biotechnology market?

    The major growth drivers of the Animal Biotechnology market include the rising demand for animal-derived products, increasing prevalence of animal diseases, growing adoption of precision livestock farming, and technological advancements in gene editing and reproductive technologies.

    What are the major applications of Animal Biotechnology?

    Animal Biotechnology finds applications in various sectors, including livestock breeding and genetics, veterinary diagnostics and therapeutics, animal nutrition and health management, and production of biopharmaceuticals and vaccines.

    Who are the key competitors in the Animal Biotechnology market?

    Some of the prominent players in the Animal Biotechnology market are Thermo Fisher Scientific, Merck & Co., Inc., Zoetis, Inc., Bayer AG, and Neogen Corporation.

    What are the challenges faced by the Animal Biotechnology market?

    The Animal Biotechnology market faces certain challenges, such as ethical concerns regarding genetic modification, regulatory hurdles, and potential risks associated with the use of genetically modified animals.

    What are the emerging trends in the Animal Biotechnology market?

    Emerging trends in the Animal Biotechnology market include the integration of artificial intelligence, machine learning, and big data analytics in animal breeding and health management, as well as the development of personalized and targeted therapies for animal diseases.

    What is the expected impact of COVID-19 on the Animal Biotechnology market?

    The COVID-19 pandemic had a significant impact on the Animal Biotechnology market, disrupting supply chains and affecting research and development activities. However, the market is expected to recover and continue its growth trajectory in the post-pandemic period.

    What are the regulatory considerations for Animal Biotechnology products?

    Regulatory considerations for Animal Biotechnology products vary across different regions. Key regulatory bodies include the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Organisation for Animal Health (OIE).

    What are the ethical implications of Animal Biotechnology?

    Animal Biotechnology raises ethical concerns related to animal welfare, environmental impact, and potential unintended consequences of genetic modifications. Ongoing debates and discussions address the responsible use and regulation of Animal Biotechnology.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials